Serum adiponectin and leptin levels in psoriatic patients according to topical treatment

Journal of Dermatological Treatment

Volumn 26, Issue 2, 2015, Pages 134-138

  Baran, A ^a   Flisiak, I ^a   Jaroszewicz, J ^a   Swiderska, M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Adipokines; Adiponectin; Leptin; Psoriasis; Psoriasis therapy

Indexed keywords

ADIPONECTIN; DITHRANOL; LEPTIN; SALICYLIC ACID; ADIPOQ PROTEIN, HUMAN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MALE; OINTMENT; PRIORITY JOURNAL; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; TOPICAL TREATMENT; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; PSORIASIS; YOUNG ADULT;

EID: 84930815164     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2014.915917     Document Type: Article

References (36)

1. Green L. An overview and update of psoriasis. Nurs Stand. 2011;25: 47-55.
2. Gudjonsson J, Elder J. Psoriasis: epidemiology. Clin Dermatol. 2007;25:535-46.
3. Liu Y, Krueger J, Bowcock A. Psoriasis: genetic associations and immune system changes. Genes Immun. 2007;8:1-12.
4. Ryan S. Psoriasis: characteristics, psychosocial effects and treatment options. Br J Nurs. 2010;19:820, 822-5.
5. Farley E, Menter A. Psoriasis: comorbidities and associations. G Ital Dermatol Veneorol. 2011;146:9-15.
6. Kim N, Thrash B, Menter A. Comorbidities in psoriasis patients. Semin Cutan Med Surg. 2010;29:10-15.
7. Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007;157:68-73.
8. Love TJ, Qureshi AA, Karlson EW, et al. Prevalence of metabolic syndrome in psoriasis. Results from the national health and nutrition examination survey, 2003-2006. Arch Dermatol. 2011;147: 419-24.
9. Alsufyani M, Golant A, Lebwohl M. Psoriasis and the metabolic syndrome. Dermatol Ther. 2010;23:137-43.
10. Chen YJ, Wu CY, Shen JL, et al. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol. 2008;144:1571-5.
11. Gerdes S, Rostami-Yazdi M, Mrowietz U. Adipokines and psoriasis. Exp Dermatol. 2011;20:81-7.
12. Herron MD, Hinckley M, Hoffman MS, et al. The impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005;141:1527-34.
13. Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and stressfull life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol. 2005; 125:61-7.
14. Bik W. To assess the relationship secretion of adipokines and insulin resistance and association of selected polymorphisms of adiponectin and resistin genes in obesity. Post Nauk Med. 2009;12: 912-80.
15. Skrzeczyńska-Moncznik J, Wawro K, Stefańska A, et al. Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin. Biochem Biophys Res Commun. 2009;380: 323-27.
16. Kirby B, Richards H, Karvonen J, et al. Alcohol consumption and psychological distress in patients with psoriasis. Br J Dermatol. 2008;158:138-40.
17. Coimbra S, Oliveira H, Reis F, et al. Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. J Eur Acad Dermatol Venereol. 2010;24: 1386-94.
18. Conde J, Scotece M, Gómez R, et al. At the crossroad between immunity and metabolism: focus on leptin. Expert Rev Clin Immunol. 2010;6:801-8.
19. Shibata S, Tada Y, Hau C, et al. Adiponectin as an antiinflammatory factor in the pathogenesis of psoriasis: induction of elevated serum adiponectin levels following therapy. Br J Dermatol. 2011;164:667-70.
20. Cerman AA, Bozkurt S, Sav A, et al. Serum leptin levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol. 2008;159: 820-6.
21. Chandran M, Phillips S, Ciaraldi T, et al. Adiponectin: more than just another fat cell hormone? Diabetes Care. 2003;26: 2442-50.
22. Flisiak I, Zaniewski P, Rogalska M, et al. Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales. Cytokine. 2010;52:225-9.
23. Fredriksson T, Pettersen U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica. 1978;157:238-44.
24. Kaur S, Zilmer K, Leping V, Zilmer M. The levels of adiponectin and leptin and their relation to other markers of cardiovascular risk in patients with psoriasis. J Eur Acad Dermatol Venereol. 2011;25: 1328-33.
25. Takahashi H, Tsuji H, Takahashi I, et al. Plasma adiponectin and leptin levels in Japanese patients with psoriasis. Br J Dermatol. 2008;159:1207-8.
26. Janusz I, Lewandowski K, Lukamowicz J, et al. Assessment of insulin resistance and adiponectin in patients with psoriasis vulgaris. Adv Dermatol Alergol. 2010;XXVII:451-5.
27. Johnston A, Arnadottir S, Gudjonsson JE. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol. 2008;159:342-50.
28. Kaur S, Zilmer K, Kairane C, et al. Clear differences in adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis. Br J Dermatol. 2008;159: 1364-7.
29. Nakajima H, Nakajima K, Tarutani M, et al. Kinetics of circulating cytokines and adipokines in psoriasis patients. Arch Dermatol Res. 2011;303:451-5.
30. Gerdes S, Osadtschy S, Rostami-Yazdi M, et al. Leptin, adiponectin, visfatin and retinol-binding protein-4-mediators of comorbidities in patients with psoriasis? Exp Dermatol. 2012; 21:43-7.
31. Ozdemir M, Yüksel M, Gökbel H, et al. Serum leptin, adiponectin, resistin and ghrelin levels in psoriatic patients treated with cyclosporine. J Dermatol. 2012;39:443-8.
32. Abdel Hay RM, Rashed LA. Association between the leptin gene 2548G/A polymorphism, the plasma leptin and the metabolic syndrome with psoriasis. Exp Dermatol. 2011;20: 715-19.
33. Wang Y, Chen J, Zhao Y, et al. Psoriasis is associated with increased levels of serum leptin. Br J Dermatol. 2008;158:1134-5.
34. Corbetta S, Angioni R, Cattaneo A, et al. Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipocytokines. Eur J Endocrinol. 2006;154:83-6.
35. Shibata S, Tada Y, Hau C, et al. Adiponectin as an antiinflammatory factor in the pathogenesis of psoriasis: induction of elevated serum adiponectin levels following therapy. Br J Dermatol. 2011;164:667-70.
36. Kawashima K, Torii K, Furuhashi T, et al. Phototherapy reduces serum resistin levels in psoriasis patients. Photodermatol Photoimmunol Photomed. 2011;27:152-5.